383 related articles for article (PubMed ID: 18559420)
21. A new chondrogenic differentiation initiator with the ability to up-regulate SOX trio expression.
Noguchi K; Watanabe Y; Fuse T; Takizawa M
J Pharmacol Sci; 2010; 112(1):89-97. PubMed ID: 20051655
[TBL] [Abstract][Full Text] [Related]
22. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.
Sekiya I; Tsuji K; Koopman P; Watanabe H; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Biol Chem; 2000 Apr; 275(15):10738-44. PubMed ID: 10753864
[TBL] [Abstract][Full Text] [Related]
23. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
Akiyama H; Chaboissier MC; Martin JF; Schedl A; de Crombrugghe B
Genes Dev; 2002 Nov; 16(21):2813-28. PubMed ID: 12414734
[TBL] [Abstract][Full Text] [Related]
25. A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6.
Yasuda H; Oh CD; Chen D; de Crombrugghe B; Kim JH
J Biol Chem; 2017 Jan; 292(2):528-538. PubMed ID: 27881681
[TBL] [Abstract][Full Text] [Related]
26. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation.
Smits P; Li P; Mandel J; Zhang Z; Deng JM; Behringer RR; de Crombrugghe B; Lefebvre V
Dev Cell; 2001 Aug; 1(2):277-90. PubMed ID: 11702786
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling.
Chimal-Monroy J; Rodriguez-Leon J; Montero JA; Gañan Y; Macias D; Merino R; Hurle JM
Dev Biol; 2003 May; 257(2):292-301. PubMed ID: 12729559
[TBL] [Abstract][Full Text] [Related]
28. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
[TBL] [Abstract][Full Text] [Related]
29. Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation.
Ikeda T; Kawaguchi H; Kamekura S; Ogata N; Mori Y; Nakamura K; Ikegawa S; Chung UI
J Bone Miner Metab; 2005; 23(5):337-40. PubMed ID: 16133682
[No Abstract] [Full Text] [Related]
30. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
[TBL] [Abstract][Full Text] [Related]
31. Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs.
Smits P; Lefebvre V
Development; 2003 Mar; 130(6):1135-48. PubMed ID: 12571105
[TBL] [Abstract][Full Text] [Related]
32. Differential tissue specific, temporal and spatial expression patterns of the Aggrecan gene is modulated by independent enhancer elements.
Li IMH; Liu K; Neal A; Clegg PD; De Val S; Bou-Gharios G
Sci Rep; 2018 Jan; 8(1):950. PubMed ID: 29343853
[TBL] [Abstract][Full Text] [Related]
33. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes.
Saito T; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
EMBO Rep; 2007 May; 8(5):504-9. PubMed ID: 17396138
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9.
Zhang P; Jimenez SA; Stokes DG
J Biol Chem; 2003 Jan; 278(1):117-23. PubMed ID: 12399468
[TBL] [Abstract][Full Text] [Related]
35. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene.
Liu Y; Li H; Tanaka K; Tsumaki N; Yamada Y
J Biol Chem; 2000 Apr; 275(17):12712-8. PubMed ID: 10777565
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of the human long form of Sox5 (L-SOX5) gene.
Ikeda T; Zhang J; Chano T; Mabuchi A; Fukuda A; Kawaguchi H; Nakamura K; Ikegawa S
Gene; 2002 Sep; 298(1):59-68. PubMed ID: 12406576
[TBL] [Abstract][Full Text] [Related]
37. Computational identification and functional validation of regulatory motifs in cartilage-expressed genes.
Davies SR; Chang LW; Patra D; Xing X; Posey K; Hecht J; Stormo GD; Sandell LJ
Genome Res; 2007 Oct; 17(10):1438-47. PubMed ID: 17785538
[TBL] [Abstract][Full Text] [Related]
38. The SOX9 upstream region prone to chromosomal aberrations causing campomelic dysplasia contains multiple cartilage enhancers.
Yao B; Wang Q; Liu CF; Bhattaram P; Li W; Mead TJ; Crish JF; Lefebvre V
Nucleic Acids Res; 2015 Jun; 43(11):5394-408. PubMed ID: 25940622
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
Kamachi Y; Cheah KS; Kondoh H
Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536
[TBL] [Abstract][Full Text] [Related]
40. Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with bone morphogenetic protein-2 under hypoxia.
Legendre F; Ollitrault D; Hervieu M; Baugé C; Maneix L; Goux D; Chajra H; Mallein-Gerin F; Boumediene K; Galera P; Demoor M
Tissue Eng Part C Methods; 2013 Jul; 19(7):550-67. PubMed ID: 23270543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]